Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroinflammation as a Therapeutic Target in Heart Failure-Related Cognitive Decline: A Feasibility PET Study

NCT07856043 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT07856043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07856043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroinflammation as a Therapeutic Target in Heart Failure-Related Cognitive Decline: A Feasibility PET Study
Lead sponsor
Stony Brook University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 31, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, mild, heart failure with reduced ejection fraction, neuroinflammation, vascular contributions to cognitive impairment and dementia (vcid)